Pancreatic Cancer Drug Trend 2026

Targeted therapies and chemotherapy regimens form the backbone of modern pancreatic cancer drug treatment. These medications work by disrupting cancer cell growth or enhancing immune response, often administered via infusion or oral pills. They are primarily used to shrink tumors, manage symptoms, and extend survival. Patients with advanced, metastatic, or inoperable pancreatic cancer—particularly those with specific genetic markers—benefit most from these precision medicines.